维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Neofytos"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Complications of modern pancreaticoduodenectomy:A systematic review and meta-analysis显示文摘Background:In the past decades,the perioperative management of patients undergoing pancreaticoduo-denectomy(PD)has undergone major changes worldwide.This review aimed to systematically determine the burden of complications of PD performed in the last 10 years.Data sources:A systematic review was conducted in PubMed for randomized controlled trials and ob-servational studies reporting postoperative complications in at least 100 PDs from January 2010 to April 2020.Risk of bias was assessed using the Cochrane RoB2 tool for randomized studies and the method-ological index for non-randomized studies(MINORS).Pooled complication rates were estimated using random-effects meta-analysis.Heterogeneity was investigated by subgroup analysis and meta-regression.Results:A total of 20 randomized and 49 observational studies reporting 63229 PDs were reviewed.Mean MINORS score showed a high risk of bias in non-randomized studies,while one quarter of the ran-domized studies were assessed to have high risk of bias.Pooled incidences of 30-day mortality,overall complications and serious complications were 1.7%(95%CI:0.9%-2.9%;I 2=95.4%),54.7%(95%CI:46.4%-62.8%;I 2=99.4%)and 25.5%(95%CI:21.8%-29.4%;I 2=92.9%),respectively.Clinically-relevant postopera-tive pancreatic fistula risk was 14.3%(95%CI:12.4%-16.3%;I 2=92.0%)and mean length of stay was 14.8 days(95%CI:13.6-16.1;I 2=99.3%).Meta-regression partially attributed the observed heterogeneity to the country of origin of the study,the study design and the American Society of Anesthesiologists class.Conclusions:Pooled complication rates estimated in this study may be used to counsel patients scheduled to undergo a PD and to set benchmarks against which centers can audit their practice.However,cautious interpretation is necessary due to substantial heterogeneity.	Stamatios Kokkinakis Evangelos I Kritsotakis Neofytos Maliotis Ioannis Karageorgiou Emmanuel Chrysos Konstantinos Lasithiotakis	2022	Hepatobiliary & Pancreatic Diseases International2022，21，6：	2
2	The PATH(Prospective Antifungal Therapy)Alliance registry and invasive fungal infections:update 2012显示文摘	Azie N Neofytos D Pfaller M	2012	Diagn Microbiol Infect Dis2012，73，4：	1
3	Epidemiology and outcomes of candidemia in 2019 patients: data from the pro- spective antifungal therapy alliance registry 显示文摘	Horn DL Neofytos D Anaissie EJ	2009	Clin Infect Dis2009，48，：	1
4	The PATH(prospective anti- fungal therapy) alliance registry and invasive fungal infections: update 2012 显示文摘	Azie N Neofytos D Pfaller M	2012	Diagn Microbiol Infect Dis2012，73，4：	1
5	Epidemiology and out- comes of candidemia in 2019 patients:data from the prospective antifungal therapy alliance registry 显示文摘	Horn DL Neofytos D Anaissie EJ	2009	Clin Infect Dis2009，48，12：	1
6	Epidemiology and outcome of invasive fungal infection in adult hematopoiet- ic stem cell transplant recipients:Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance regis- try显示文摘	Neofytos D Horn D Anaissie E	2009	Clin Infect Dis2009，48，3：	1
7	Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients:analysis of Multicenter Prospective Antifungal Therapy (PATH)Alliance registry显示文摘	Neofytos D Horn D Anaissie E		0，，03：	1
8	Administration of voriconazole in patients with ren~ dysfunction显示文摘	NEOFYTOS D LOMBARDI LR SHIELDS RK al	2012	Clin Infect Dis2012，54，7：	1
9	Epidemiology and outcome of candidemia in 2019 patients: date form the pro spective antifungal therapy alliance registry 显示文摘	Horn DL Neofytos D Anaissie EJ	2009	Clin infect Dis2009，48，12：	1
10	Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem celltransplant recipients:analysis of multicenter prospective antifungal therapy(PATH)alliance registry显示文摘	Neofytos D Horn D Anaissie E	2009	Clin Infect Dis2009，48，3：	1
11	Epidemiology and out- comes of candidemia in 2019 patients:data from the prospective antifungal therapy alliance registry 显示文摘	Horn DL Neofytos D Anaissie EJ	2009	Clin Infect Dis2009，48，12：	1
12	Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir显示文摘	Dionissios Neofytos Ambrish Ojha Bijoyesh Mookerjee John Wagner Joanne Filicko Andres Ferber Scott Dessain Dolores Grosso Janet Brunner Neal Flomenberg Phyllis Flomenberg	2007	Biology of Blood and Marrow Transplantation2007，，1：	1
13	Epidemiology and outcomes of candidemia in 2019 patients:data from the prospective antifungal therapy alliance registry显示文摘	Horn D L Neofytos D Anaissie E J	2009	Clin Infect Dis2009，48，12：	1
14	The PATH ( Prospective Antifun-gal Therapy) Alliance( R) registry and invasive fungal infections: up-date 2012 显示文摘	Azie N Neofytos D Pfaller M	2012	Diagn Microbiol Infect Dis2012，73，4：	1
15	Epidemiology and out- come of invasive fungal infections in solid organ transplant recipients 显示文摘	Neofytos D Fishman J A Horn D	2010	Transpl Infect Dis2010，12，3：	1
16	The PATH (Prospective Antifungal Therapy) Alliance registry and invasive fungal infections: update 2012显示文摘	Azie N Neofytos D Pfaller M	2012	Diagn Microbiol Infect Dis2012，73，4：	1
17	Epidemiology and out- come of invasive fungal infection in adult hematopoietic stern cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry 显示文摘	Neofytos D Hom D Anaissie E	2009	Clin Infect Dis2009，48，3：	1
18	The PATH (Prospective Antifungal Theraphy) Alliance registry and invasive fungal infections:update 2012 显示文摘	Azie N Neofytos D Pfaller M	2012	Diagan Microbiol Infect Dis2012，73，4：	1
19	Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell trans plant recipients= analysis of multicenter prospective antifongal therapy(PATH) alliance registry显示文摘	Neofytos D Horn D Anaissie E	2009	Clin Infect Dis2009，48，3：	1
20	The PATH (Prospective Antifungal Therapy) Alliance? registry and invasive fungal infections: update 2012显示文摘	Nkechi Azie Dionissios Neofytos Michael Pfaller Herwig-Ulf Meier-Kriesche Shun-Ping Quan David Horn	2012	Diagnostic Microbiology & Infectious Disease2012，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示